Nanocurcumin was linked to better disability scores in small RRMS trials, but researchers say larger studies are needed.

Tolebrutinib has been approved in the European Union under the brand name Cenrifki for treating nonrelapsing secondary ...

An experimental MS therapy given as a nasal spray has started dosing its final participant in a Phase 2a trial of people with ...

Changes in the upper spinal cord, measured on routine brain MRI, may help flag higher MS progression risk in people with RRMS ...

A gene variant tied to more severe MS disability may also correlate with poor cognitive performance in healthy adults, per a ...

AI analysis of bacteria and other gut microorganisms can help distinguish between people with and without multiple sclerosis, ...

Supplementation with high-dose vitamin D for more than one year significantly reduced relapse risk and eased disability in ...

MMR and chickenpox vaccines don't raise relapse risk for people with MS, a study found, supporting current vaccination ...

High-intensity physical exercise combined with melatonin supplements may offer more benefit to people with MS than either ...

Aspirin and acetaminophen may help ease MS fatigue, improve temperature regulation, and increase exercise capacity, a study ...

Before her diagnosis, columnist Desiree Lama rarely questioned every sensation, but now she wonders if everything is a ...

Late-onset MS patients are more likely to accumulate disability through mechanisms not directly linked to relapses, per a ...